Ritonavir/saquinavir safety concerns curtail antiretroviral therapy options for tuberculosis–HIV-co-infected patients in resource-constrained settings.
| dc.contributor.author | Gray, Andrew Lofts. | |
| dc.contributor.author | Abdool Karim, Salim Safurdeen. | |
| dc.contributor.author | Gengiah, Tanuja Narayansamy. | |
| dc.date.accessioned | 2013-05-07T09:44:49Z | |
| dc.date.available | 2013-05-07T09:44:49Z | |
| dc.date.created | 2005 | |
| dc.date.issued | 2005 | |
| dc.description | Correspondence | en |
| dc.description.abstract | No abstract available. | en |
| dc.identifier.citation | Gray, A.L., Abdool Karim, S.S. & Gengiah, T.N. 2006. Ritonavir/saquinavir safety concerns curtail antiretroviral therapy options for tuberculosis–HIV-co-infected patients in resource-constrained settings. AIDS 20(2) pp. 302-303. | en |
| dc.identifier.issn | 0269-9370 | |
| dc.identifier.uri | http://hdl.handle.net/10413/8835 | |
| dc.language.iso | en | en |
| dc.publisher | Lippincott Williams & Wilkins. | en |
| dc.subject | Highly active antiretroviral treatment. | en |
| dc.subject | HIV infections--Treatment. | en |
| dc.subject | Tuberculosis--Treatment. | en |
| dc.subject.other | Antiretroviral therapy. | en |
| dc.subject.other | Ritonavir/saquinavir. | en |
| dc.subject.other | Tuberculosis-HIV co-infected patients. | en |
| dc.subject.other | Co-infection. | en |
| dc.subject.other | HAART. | en |
| dc.title | Ritonavir/saquinavir safety concerns curtail antiretroviral therapy options for tuberculosis–HIV-co-infected patients in resource-constrained settings. | en |
| dc.type | Other | en |